Immunotherapy's hidden side effect: new study tracks autoimmune risks
NCT ID NCT04220034
First seen Dec 16, 2025 · Last updated May 08, 2026 · Updated 22 times
Summary
This study tracked 183 cancer patients receiving checkpoint inhibitors to see how often they develop autoantibodies (immune system proteins that attack the body) or autoimmune diseases. Researchers measured changes in several autoantibodies over time. The goal was to better understand and monitor these side effects, which can range from mild to severe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE ADVERSE EFFECTS OF ANTI-NEOPLASIC DRUG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu Reims
Reims, 51092, France
Conditions
Explore the condition pages connected to this study.